Immunotherapy Profiling Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
5,000
NCT04340024
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Phase: N/A
Role: Collaborator
Start: Sep 30, 2015
Completion: Dec 31, 2026
Loading map...